Prof. Dr. Ralf Wagner

Further involvements

• 28/03/2023

  • Poster
  • P 405

  Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene expression across passages

   Vaccines, Viral vectors and gene therapy
• 28/03/2023

  • Poster
  • P 001

  Population-based study of the durability of humoral immunity after SARS-CoV-2 infection

   Adaptive immunity
• 28/03/2023

  • Poster
  • P 340

  N-glycosylation enzymes are critical for binding and functionality of an HIV-1 broadly neutralizing antibody involved in trogocytotic immune cell communication

   Antiviral therapy and resistance, Viral pathogenesis and persistence
• 28/03/2023

  • Poster
  • P 402

  Towards HERV-H Env protein-based tumor stratification and intervention strategies

   Viral transformation and oncogenesis
• 28/03/2023

  • Poster
  • P 235

  Heterologous SARS-CoV-2 delta breakthrough infection elicits broader and more durable neutralizing antibody response than (non-breakthrough) infection

   Epidemiology and public health, SARS-CoV-2
• 28/03/2023

  • Poster
  • P 135

  Higher infection risk among health care workers and lower risk among smokers persistent across SARS-CoV-2 waves – longitudinal results from the population-based TiKoCo seroprevalence study

   Epidemiology and public health, SARS-CoV-2
• 28/03/2023

  • Poster
  • P 310

  Generation and characterization of an Adenoviral vaccine candidate expressing the pentameric complex of human cytomegalovirus

   Adaptive immunity, Vaccines
• 28/03/2023

  • Poster
  • P 298

  Breakthrough infection with Omicron variants induces persistent and broadly cross-reactive adaptive immunity and associates with protection from reinfection

   SARS-CoV-2, Vaccines
• 28/03/2023

  • Poster
  • P 299

  Ex vivo characterization of IE-1/pp65-expressing adenoviral vectors as potential T cell vaccine candidates for human Cytomegalvirus

   Adaptive immunity, Vaccines
• 28/03/2023

  • Poster
  • P 114

  Neutralizing Influenza A H1N1 using functionalized DNA-origami nanoshells

   Emerging viruses and zoonosis
• 28/03/2023

  16:15 – 16:30 12 Min. 3 Min.

  • Abstract Talk
  • O 003

  CD32 drives autoantibody-enhanced trogocytosis to facilitate HIV-1 infection of resting CD4 T cells

   Host cell factors and modulation, Virus receptors and entry
• 28/03/2023

  16:45 – 17:00 12 Min. 3 Min.

  • Abstract Talk
  • O 017

  Establishing a virus-free antibody binding inhibition assay using a synthetic Notch receptor

   Diagnostic methods and tools, SARS-CoV-2
• 31/03/2023

  11:15 – 11:30 12 Min. 3 Min.

  • Abstract Talk
  • O 117

  Trivalent MVA-based vaccine candidate induces a potent immune response against Sudan Ebolavirus, Marburg and Lassa fever virus in guinea pigs

   Vaccines, Viral vectors and gene therapy